Baxter International edges higher with sector peers, shares trade on NYSE

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-28, 14:31.

Baxter International Inc. (US0673431090) closed the latest NYSE session at 22.04 US dollars on 26 June 2026, marking a 2.27 percent gain for the day compared with the previous close. The move came on solid trading volume above 10 million shares, broadly consistent with interest in large-cap medical-technology names.

How Baxter shares ended the week

According to MarketBeat data, Baxter shares finished regular trading on the NYSE at 22.04 US dollars on 26 June 2026, after adding 0.49 dollars or 2.27 percent in that session. Extended trading later that day saw the shares at 21.98 US dollars at 19:50 Eastern time, a modest 0.29 percent decline from the regular close.

Price data from PandaForecast show intraday levels for Baxter on 26 June with an open at 21.47 US dollars, a high at 22.175 dollars and a low at 21.43 dollars, with a closing value listed at 22.04 dollars. Trading volume for that session reached 10,260,238 shares, indicating active participation despite the relatively small price move in percentage terms.

Analyst expectations and sector comparison

PandaForecast reports a near-term analyst consensus price indication around 21.54 US dollars for Baxter, slightly below the latest closing price of 22.04 dollars. This implies a muted upside according to that model, reflecting cautious sentiment on the stock after a period of operational restructuring in the medtech sector.

MarketBeat’s overview categorizes Baxter within the medical instruments and supplies segment, alongside peers such as Becton Dickinson and Medtronic, which also trade on major US indices like the S&P 500 and the Dow Jones Industrial Average. In that context, Baxter’s late-week gain of just over two percent sits within a modest range compared with larger swings seen in more volatile healthcare names.

How Baxter makes its money

Baxter International generates the bulk of its revenue from medical products used in hospitals and clinics, including intravenous (IV) solutions, infusion pumps and dialysis equipment for patients with kidney disease. The company also sells anesthesia and critical-care products, supporting therapies in intensive-care units worldwide.

Where the Baxter shares trade today

The Baxter International shares (US0673431090) most recently traded on the NYSE at 22.04 US dollars at the close on 2026-06-26. The listing forms part of the broader US healthcare cohort, with price data referenced against the S&P 500 and sector benchmarks.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell Baxter International shares or any other securities.